Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
FDA has approved dipeptidyl peptidase-4 (DPP-IV) resistant long-acting GLP-1s as injectable drugs for treating patients with type 2 diabetes
However, the dosing regimen may differ, so it's imperative to follow the recommendations of a healthcare professional
Foundayo (orforglipron) Foundayo ( orforglipron ) is a once-daily oral GLP-1 medication that was FDA-approved for chronic weight management in April 2026
Project of Administration of Traditional Chinese Medicine of Guangdong Province of China (20211403)
US$ 29.17
US$ 21.80
US$ 21.84
US$ 27.51
US$ 21.61
US$ 20.92
